Professor, Neurology, USF-Morsani
Neurology
Dr. Theresa Zesiewicz, MD
|
|
Give Review
Theresa Zesiewicz is an expert in the field of Neurology. She graduated from Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76 in research and 0 in primary care medicine She has 1 awards "CMS Meaningful Use Stage 1 Certification". Theresa Zesiewicz, MD is a published doctor. She has 94 publications published. The most current publication "Sertraline for the treatment of depression in Parkinson's disease." She is registered with Medicare and accepts Medicare payments.
Publications
- Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's Disease.
- Gait and balance in adults with Friedreich's Ataxia.
- Medical marijuana in neurology.
- Treatment of cerebellar Ataxia.
- Clinical Evaluation of Eye Movements in Spinocerebellar Ataxias: A Prospective Multicenter Study.
- Autologous stem cell transplant with gene therapy for Friedreich Ataxia.
- Unusual wrist Tremor: unilateral isometric Tremor?
- Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's Disease: an overview.
- Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar Ataxia.
- Analysis of the visual system in Friedreich Ataxia.
- Randomized trial of cognitive speed of processing training in Parkinson Disease.
- Update on treatment of Essential tremor.
- Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor.
- Methodological issues in clinical drug development for Essential tremor.
- Impact of discontinuing tremor suppressing medications following thalamic deep Brain stimulation.
- Vascular risk factors and clinical progression in spinocerebellar Ataxias.
- Evidence-based guideline update: treatment of Essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.
- Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive.
- A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar Ataxia type 3.
- Practice Parameter: treatment of nonmotor symptoms of Parkinson Disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.
- Ropinirole in the treatment of Parkinson''s Disease.
- Practice parameter: therapies for Essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
- Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson Disease (an evidence-based review): report of the Quality Standards Subcommittee...
- Practice Parameter: diagnosis and prognosis of new onset Parkinson Disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Aca...
- Clinical trials of add-on medications in Parkinson''s Disease: Efficacy versus usefulness.
- Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/Ataxia syndrome.
- Phenomenology and treatment of tremor Disorders.
- Neurosurgery for Parkinson's Disease.
- Modafinil treatment of pramipexole-associated somnolence.
- Pramipexole-induced somnolence and episodes of daytime sleep.
- A home diary to assess functional status in patients with Parkinson's Disease with motor fluctuations and dyskinesia.
- Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's Disease.
- Current issues in depression in Parkinson's Disease.
- Management of early Parkinson's Disease.
- Sertraline for the treatment of depression in Parkinson's Disease.
- Manganese and chronic liver Disease.
- Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver Disease.
- Sertraline-induced exacerbation of tics in Tourette's Syndrome.
- Clinical predictors of abnormality disclosed by computed tomography after mild head Trauma.
- Manganese intoxication and chronic liver failure.
- Driving safety in Parkinson's Disease.
- Heart failure in Parkinson''s Disease: analysis of the United States medicare current beneficiary survey.
- Social Security Disability Insurance (SSDI) in Parkinson''s Disease.
- Low-dose topiramate (topamax) in the treatment of Essential tremor.
- Tiagabine and exacerbation of Essential tremor.
- Levodopa-induced dyskinesia in Parkinson's Disease: epidemiology, etiology, and treatment.
- A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of Essential tremor.
- Advances in the pharmacologic management of early Parkinson Disease.
- Prevalence and treatment of non-motor symptoms in Parkinson''s Disease.
- Nonmotor symptoms of Parkinson''s Disease.
- A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of Essential tremor.
- Pregabalin (Lyrica) in the treatment of Essential tremor.
- Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's Disease.
- Chorea induced by lamotrigine.
- Zonisamide-induced mania in an Essential tremor patient.
- Topiramate-induced psychosis in patients with Essential tremor: report of 2 cases.
- The controversy concerning plasma homocysteine in Parkinson Disease patients treated with levodopa alone or with entacapone: effects of vitamin status.
- Clinical trials aimed at detecting neuroprotection in Parkinson's Disease.
- Use of nutritional supplements in Parkinson's Disease patients.
- Substantial improvement in a Meige's Syndrome patient with levetiracetam treatment.
- Essential tremor. Epidemiology, diagnosis, and treatment.
- Botulinum toxin A for the treatment of cervical Dystonia.
- Sleep attacks and dopamine agonists for Parkinson''s Disease: what is currently known?
- Clozapine withdrawal symptoms in a Parkinson's Disease patient.
- Management of Essential tremor.
- Subjective improvement in proprioception in 2 patients with atypical Friedreich Ataxia treated with varenicline (Chantix).
- Stiff-person Syndrome: commonly mistaken for hysterical paralysis.
- Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson Disease.
- Treatment of Ataxia and imbalance with varenicline (chantix): report of 2 patients with spinocerebellar Ataxia (types 3 and 14).
- Levetiracetam for stiff-person Syndrome: report of 2 patients.
- Deep Brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations.
- Red flags to spot the parkinsonian variant of Multiple system atrophy.
- Delayed thalamic intracranial hemorrhage in an essential tremor patient following deep Brain stimulation.
- Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1.
- Vascular hemiChorea/hemiballismus and topiramate.
- Treatment of Chorea with levetiracetam.
- Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's Disease.
- Levetiracetam-induced parkinsonism in a Huntington Disease patient.
- Levetiracetam for the treatment of generalized Dystonia.
- Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson''s Disease.
- Levetiracetam for the treatment of Essential tremor.
- Chorea in a patient with Cerebral palsy: treatment with levetiracetam.
- Drug-induced hyperkinetic movement Disorders by nonneuroleptic agents.
- Delayed clinical improvement after deep Brain stimulation-related subdural hematoma.
- Overview of Essential tremor.
- Reduction of circulating endothelial cells in Peripheral blood of ALS patients.
- Sleep disorders in Parkinson''s Disease.
- Potential influences of complementary therapy on motor and non-motor complications in Parkinson''s Disease.
- Depressive symptoms in Parkinson Disease: degree of association and rate of agreement of clinician-based and self-report measures.
- Parkinson Disease: the controversy of levodopa toxicity in Parkinson Disease.
- Quantitative analysis of Tremors in welders.
- Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical Dystonia symptoms.
- Evaluation of humoral immune response in adaptive immunity in ALS patients during Disease progression.
Schools
UMDNJ New Jersey Medical School
UmdNj
SUNY Downstate
University South Fla
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Brain Injury
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
SUNY Health Science Center at Brooklyn -
UMDNJ-University Hospital -
Rutgers New Jersey Medical School
Hospital
-
Memorial Hospital of Tampa -
Tampa General Hospital
Drug Facts
| NPI NUMBER | 1265455315 | |
| NPPES Provider LastName | ZESIEWICZ | |
| NPPES Provider FirstName | THERESA | |
| NPPES Provider ZIPCode | 336124742 | |
| NPPES Provider State | FL | |
| Specialty Description | Neurology | |
| Total Claim Count | 2692.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265455315 |
| Last Name Of The Provider | ZESIEWICZ |
| First Name Of The Provider | THERESA |
| View All |
Similar Doctors
|
Dr. Jose A. Ferreira, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosanna L. Garner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil Kumar S. Reddy, MD |
|
Dr. Jamie W. Fernandez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eugeniu V. Muntean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amos Gipson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Denise K. Griffin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rossitza I. Chichkova, MD |
|
|
Dr. Kimberly A. Tobon, DO |
|
|
Dr. Mohammed N. Zaman, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ezra S. Elkayam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crystal Dixon, MD |
|
|
Dr. Jigar M. Rathod, MD |